Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations

Hims & Hers Health (NYSE:HIMS) First Quarter 2025 Results

Key Financial Results

• Revenue: US$586.0m (up 111% from 1Q 2024).
• Net income: US$49.5m (up 345% from 1Q 2024).
• Profit margin: 8.4% (up from 4.0% in 1Q 2024). The increase in margin was driven by higher revenue.
• EPS: US$0.22 (up from US$0.052 in 1Q 2024).

Our free stock report includes 2 warning signs investors should be aware of before investing in Hims & Hers Health. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Hims & Hers Health Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 8.7%. Earnings per share (EPS) also surpassed analyst estimates by 65%.

Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 27% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Hims & Hers Health (of which 1 doesn't sit too well with us!) you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.